FLASH SPRING SALE: 50% Off Premium Subscription >> FLASH SPRING SALE: 50% Off Premium >>
$0.396
+0.0060 (+1.54%)
At Close: May 01, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.371 $0.93 Wednesday, 1st May 2024 SNGX stock ended at $0.396. This is 1.54% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 5.08% from a day low at $0.390 to a day high of $0.410.
90 days $0.371 $0.93
52 weeks $0.371 $4.20

Historical Soligenix, Inc prices

Date Open High Low Close Volume
Sep 26, 2023 $0.540 $0.545 $0.522 $0.536 151 022
Sep 25, 2023 $0.530 $0.550 $0.520 $0.530 79 780
Sep 22, 2023 $0.508 $0.530 $0.495 $0.530 45 358
Sep 21, 2023 $0.493 $0.506 $0.490 $0.502 30 757
Sep 20, 2023 $0.549 $0.549 $0.506 $0.506 45 006
Sep 19, 2023 $0.534 $0.535 $0.490 $0.533 152 509
Sep 18, 2023 $0.480 $0.530 $0.480 $0.512 160 003
Sep 15, 2023 $0.460 $0.470 $0.445 $0.464 79 286
Sep 14, 2023 $0.480 $0.500 $0.450 $0.452 86 148
Sep 13, 2023 $0.510 $0.510 $0.460 $0.477 63 140
Sep 12, 2023 $0.508 $0.508 $0.490 $0.505 52 397
Sep 11, 2023 $0.480 $0.508 $0.475 $0.508 37 711
Sep 08, 2023 $0.500 $0.508 $0.470 $0.500 39 764
Sep 07, 2023 $0.500 $0.510 $0.490 $0.510 131 617
Sep 06, 2023 $0.460 $0.510 $0.460 $0.491 191 262
Sep 05, 2023 $0.470 $0.470 $0.450 $0.460 81 987
Sep 01, 2023 $0.480 $0.483 $0.438 $0.438 53 283
Aug 31, 2023 $0.469 $0.470 $0.440 $0.450 43 885
Aug 30, 2023 $0.458 $0.470 $0.440 $0.450 72 490
Aug 29, 2023 $0.451 $0.483 $0.443 $0.460 37 148
Aug 28, 2023 $0.460 $0.480 $0.452 $0.455 84 034
Aug 25, 2023 $0.468 $0.479 $0.453 $0.470 22 263
Aug 24, 2023 $0.463 $0.484 $0.446 $0.469 56 633
Aug 23, 2023 $0.460 $0.463 $0.450 $0.460 23 215
Aug 22, 2023 $0.446 $0.474 $0.431 $0.442 40 098
Click to get the best stock tips daily for free!

About Soligenix, Inc

Soligenix Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has completed Phase III clinical trial for the treatment of treat cutaneous T-cell lymphoma; and SGX942, an ... SNGX Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT